Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit

Calle Rubio, Myriam; Miravitlles, Marc; López-Campos, José Luis; Alcázar Navarrete, Bernardino; Soler Cataluña, Juan José; Fuentes Ferrer, Manuel E; Rodríguez Hermosa, Juan Luis.
Arch. bronconeumol. (Ed. impr.) ; 59(11): 725-735, nov. 2023. ilus, tab, graf
Artigo em Inglês | IBECS (Espanha) | ID: ibc-227422

Documentos relacionados

  1. International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials.
  2. Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness.
  3. Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up.
  4. Which patients with COPD need an inhaled corticosteroid?
  5. Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit.
  6. COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry.
  7. Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea.
  8. In 'real world' patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations.
  9. Chronic Obstructive Pulmonary Disease: Diagnosis and Management.
  10. The adjusted impact of different severities of acute exacerbations and medications on the risk of developing dementia in COPD patients.